GlassScriptPhysician profile
Anthony Poggio
NPI 1013960806
$4,143.49
in general payments reported to CMS, 2019-2025
25 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $197 · 2021: $386 · 2022: $678 · 2023: $547 · 2024: $901 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,585.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,380.15 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Kerecis Limited | $495.45 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $319.01 | 2023-2025 | Infinity, Augment Injectable |
| Orthofix Medical, INC. | $297.94 | 2021-2024 | Physio-Stim, Accelstim |
| Organogenesis INC. | $196.67 | 2019-2023 | Puraply |
| Tactile Systems Technology INC | $192.42 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Alafair Biosciences, INC. | $180.63 | 2024 | Versawrap |
| Treace Medical Concepts, INC. | $174.11 | 2022-2025 | |
| Amgen INC. | $143.37 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $124.98 | 2019 | |
| Bioventus LLC | $97.55 | 2021-2023 | |
| Integra Lifesciences Corporation | $90.92 | 2020-2022 | |
| Access Pro Medical, LLC | $65.97 | 2025 | Matriderm |
| Zimmer Biomet Holdings, INC. | $56.91 | 2020-2021 | |
| Mimedx Group, INC. | $51.35 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $42.79 | 2019-2021 | |
| Kci USA, INC. | $39.80 | 2023 | V.A.C. Dermatac, Promogran Prisma, 3m Cavilon |
| Solventum Corporation | $30.92 | 2024 | Activ.A.C. |
| Paragon 28, INC. | $28.31 | 2024 | Baby Gorilla |
| Arthrosurface Incorporated | $24.07 | 2019 | |
| Nevro Corp. | $24.03 | 2023 | Senza |
| Musculoskeletal Transplant Foundation INC. | $23.95 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.75 | 2021 | |
| Paratek Pharmaceuticals, INC. | $21.57 | 2025 | Nuzyra |
| Urgo Medical North America, LLC | $16.87 | 2025 | Urgok2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Poggio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.